广谱靶向二代测序是否已准备好在重症监护病房常规用于重症肺炎
该研究为前瞻性研究的中期分析,纳入台湾一家三级医疗中心的51例成人ICU重症肺炎患者,比较基于杂交捕获的呼吸道病原体ID/AMR富集面板(RPIP)与标准检测(常规微生物检测联合FilmArray肺炎面板)对支气管肺泡灌洗样本的检测表现。RPIP分析检出率高于标准检测(90.2% vs. 82.4%),但经多学科专家裁定的致病病原比例两组相似(47.1% vs. 49.0%,McNemar精确检验p=1.00,无显著差异)。与常规微生物检测联合FilmArray肺炎面板相比,RPIP在23.5%的患者中提供了额外的临床可操作产出,主要与抗菌药物耐药决定因子相关;17.6%结果一致,13.7%RPIP产出更低,45.1%的病例经全面审查后无裁定致病病原。作者认为,靶向二代测序虽拓宽了病原与耐药检测,但在ICU常规实施需要明确指征、验证基因型-表型相关性、优化周转时间、严格污染控制及结构化多学科整合。
要点
- 在51例成人ICU重症肺炎患者中,RPIP分析检出率90.2%,标准检测82.4%。
- 经多学科专家裁定,RPIP与标准检测的致病病原比例相似(47.1% vs. 49.0%),无显著差异(McNemar精确检验p=1.00)。
- 与常规微生物检测联合FilmArray肺炎面板相比,RPIP在23.5%患者中提供额外临床可操作产出,主要与抗菌药物耐药决定因子相关。
- 45.1%的病例经全面审查后无裁定致病病原,提示综合评估后仍有近半数未能明确病原。
- 作者认为ICU常规实施靶向二代测序需明确指征、验证基因型-表型相关性、优化周转时间、严格污染控制及结构化多学科整合。
适用人群与场景
- 台湾一家三级医疗中心的成人ICU重症肺炎患者,共51例,采集支气管肺泡灌洗样本进行分析。
研究设计与关键结果
- 研究类型为前瞻性研究的中期分析,纳入51例成人ICU重症肺炎患者。
- RPIP分析检出率高于标准检测(90.2% vs. 82.4%)。
- 经多学科专家裁定的致病病原比例RPIP与标准检测相似(47.1% vs. 49.0%),无显著差异(McNemar精确检验p=1.00)。
- 与常规微生物检测联合FilmArray肺炎面板相比,RPIP在23.5%患者中提供额外临床可操作产出,主要与抗菌药物耐药决定因子相关;17.6%结果一致,13.7%RPIP产出更低。
- 45.1%的病例经全面审查后无裁定致病病原。
证据类型、等级与局限
- 证据类型为前瞻性研究的中期分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,靶向二代测序虽拓宽病原与耐药检测,但在ICU常规实施需要明确指征、验证基因型-表型相关性、优化周转时间、严格污染控制及结构化多学科整合。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Targeted next-generation sequencing (tNGS) has demonstrated higher analytical detection of respiratory pathogens than conventional microbiological tests (CMTs), yet its real-world clinical value in intensive care units (ICUs) remains uncertain. We conducted an interim analysis of a prospective study including 51 adult ICU patients with severe pneumonia at a tertiary medical center in Taiwan and examined the challenges to its routine implementation in the ICU. Bronchoalveolar lavage samples were analyzed using a hybrid capture–based Respiratory Pathogen ID/AMR Enrichment Panel (RPIP) and compared with standard testing (CMT combined with the FilmArray Pneumonia Panel [FAPP]). Causative pathogens were determined through multidisciplinary expert adjudication. RPIP showed a higher analytical detection rate than standard testing (90.2% vs. 82.4%). However, the proportion of adjudicated causative pathogens was similar between RPIP and standard testing (47.1% vs. 49.0%), with no significant difference (McNemar’s exact test, p = 1.00). After expert adjudication, RPIP provided additional clinically actionable yield in 23.5% of patients compared with CMT + FAPP, mainly related to antimicrobial resistance determinants, while 17.6% showed concordant results, 13.7% demonstrated lower yield with RPIP, and 45.1% of cases had no adjudicated causative pathogen after comprehensive review. Although tNGS broadens pathogen and resistance detection, its routine implementation in the ICU requires clearly defined indications, validated genotype–phenotype correlations, optimized turnaround time, strict contamination control, and structured multidisciplinary integration.
参考来源
- Tseng HY, Fu YC, Su YH, et al. Broad-spectrum targeted next-generation sequencing: is it ready for routine deployment in intensive care units for severe pneumonia? Crit Care. 2026. PMID: 41928273. doi:10.1186/s13054-026-05974-2
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。